PNU-96391

N/A

Report date: 2022/12/14 17:41:02
NME

Base Information

Drug NamePNU-96391
Drug Alias NameMovement disorder therapeutics(S)-(-)-OSU-6162PNU-96391OSU-6162PNU-96391A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor agonistsSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptor
Therapy Area/IndicationsDepressive Disorder, Treatment-ResistantDepressive DisorderBipolar Disorder +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenNorway
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeurosearch AsArvid Carlsson Research AB
China Registration ClassN/A

Develop Information

Active CompaniesArvid Carlsson Research ABGothenburg University
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Treatment-ResistantDepressive DisorderBipolar Disorder +[4] 
Inactive IndicationsStrokeSubarachnoid Hemorrhage

Other Information

ATC CodeN/A
Related LinksN/A